Please assess the completion status of the following clinical trial:

Trial Title: A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Body Mass Index (BMI) \>= 33 and \< 50 kg/m2~* BMI \>=30 and \< 50 kg/m2 if patients have controlled hypertension or abnormal blood lipids~* Stable weight~* Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)~* Randomization criteria: Weight reduction of more than 8% of enrollment body weight during the eight week run-in phase~Exclusion Criteria:~* Prior exposure, known contraindication, or hypersensitivity to topiramate~* Exposure to any other experimental drug or device within last 30 days~* A diagnosis of diabetes (except those diagnosed during the enrollment if no medications are needed)~* History or evidence of clinically significant liver disease, cardiovascular disease, uncontrolled hypertension or high thyroid levels~* History of obesity with known cause~* History or family history of kidney stones~* History of weight loss surgery or liposuction~* History of malignancy within last 5 years~* History of an eating disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).